Publication Name	World Journal of Gastroenterology
Manuscript ID	38660
Country	Mexico

Received	2018-03-08 02:26
Peer-Review Started	2018-03-08 03:33
First Decision by Editorial Office Director	2018-03-28 13:33
Return for Revision	2018-03-31 09:49
Revised	2018-04-04 16:42
Publication Fee Transferred
Second Decision by Editor	2018-04-13 09:35
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2018-04-15 23:14
Articles in Press	2018-04-15 23:14
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-04-25 11:13
Publish the Manuscript Online	2018-04-27 03:25

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Beneficial effects of naringenin in liver diseases: Molecular mechanisms
Manuscript Source	Invited Manuscript
All Author List	Erika Hernández-Aquino and Pablo Muriel
Funding Agency and Grant Number	Funding Agency Grant Number National Council of Science and Technology (Conacyt) of Mexico 253037
Corresponding Author	Pablo Muriel, PhD, Research Scientist, Laboratory of Experimental Hepatology, Department of Pharmacology, Cinvestav-IPN, Av. Instituto Politécnico Nacional 2508, Apartado postal 14-740, Mexico City 07360, Mexico. pmuriel@cinvestav.mx
Key Words	Naringenin; Transforming growth factor; Liver; Fibrosis; Cirrhosis; Smads; MAPKs; CCl4; Flavonoids; JNK; Hepatic stellate cells; α-SMA
Core Tip	Natural products such as flavonoids have been shown to display hepatoprotective properties. Naringenin possesses the ability to inhibit oxidative stress and inflammation and has anti-inflammatory and anticancer properties. Thus, naringenin should be considered in the future as an important candidate for the treatment of liver diseases.
Publish Date	2018-04-27 03:25
Citation	Hernández-Aquino E, Muriel P. Beneficial effects of naringenin in liver diseases: Molecular mechanisms. World J Gastroenterol 2018; 24(16): 1679-1707
URL	http://www.wjgnet.com/1007-9327/full/v24/i16/1679.htm
DOI	http://dx.doi.org/10.3748/wjg.v24.i16.1679

Full Article (PDF)	WJG-24-1679.pdf
Manuscript File	38660-Review.docx
Answering Reviewers	38660-Answering reviewers.pdf
Audio Core Tip	38660-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	38660-Conflict-of-interest statement.pdf
Copyright License Agreement	38660-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	38660-Language certificate.pdf
Peer-review Report	38660-Peer-review(s).pdf
Scientific Misconduct Check	38660-Scientific misconduct check.pdf
Scientific Editor Work List	38660-Scientific editor work list.pdf